经桡动脉直接经皮冠状动脉介入治疗现状  

The Current Status of Transradial Artery Access for Primary Percutaneous Coronary Intervention

作　　者：董丹红[1] 宋杰[1] 

机构地区：[1]南京医科大学鼓楼临床医学院心内科,南京210008

出　　处：《医学综述》2013年第4期656-658,共3页Medical Recapitulate

摘　　要：急性心肌梗死(AMI)是威胁健康的疾病之一,其治疗方式主要有直接经皮冠状动脉介入和溶栓两种,以前者占主导地位。冠状动脉介入的手术入径主要有股动脉与桡动脉,经桡动脉直接经皮冠状动脉介入在减少血管并发症、改善术后患者舒适度上占有极大优势。然而,时间在AMI的抢救中占据极其重要的地位,因此在选择治疗方式时应慎重。该文就经桡动脉直接经皮冠状动脉介入治疗的现状、安全性及有效性予以综述。Primary percutaneous coronary intervention （pPCI） and thrombolysis are the main treatments of acute myocardial infarction （AMI） which is a main threat to public health, with the former treatment in the leading position. Radial artery and femoral artery are the major puncture sites of percutaneous coronary inter- vention（PCI）. Transradial artery access fpPCI（TRA-pPCI） has the advantage of less vascular complications and higher comfort level. However, reducing rescue time plays the most important role in AMI, and we should select the treatment cautiously. Here is to make a brief review on the current status, the safety and efficacy of TRA-pPCI.

关 键 词：急性心肌梗死 桡动脉 股动脉 直接经皮冠状动脉介入 

分 类 号：R541.4[医药卫生—心血管疾病]